French Society for Intensive Care
18
5
5
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 18 trials
100.0%
+13.5% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Neuroprotective Effect of Remote Ischemic Post-conditioning in Out-of-hospital Cardiac Arrest
Role: collaborator
IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients
Role: collaborator
Evaluation of Rehabilitation Practices in the Intensive Care Unit
Role: lead
Hypercapnic Acute Respiratory Failure in the ICU : the YETI Study
Role: lead
Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidrug-resistant Gram-negative Bacteria
Role: lead
Prone Position and Renal Resistive Index
Role: collaborator
Intra-Hospital Transport of Critically Ill Patients in Intensive Care Unit
Role: lead
Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA)
Role: lead
Blood Glucose Management in Intensive Care Units
Role: lead
Neuromuscular Blockade in the Intentive Care Unit, an Observational Study.
Role: lead
Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris
Role: lead
Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU
Role: lead
End Of Life in the Critically Ill patiEnt
Role: lead
Analysis of Factors Related to Occurrence of Serious Adverse Events During Nursing in Intensive Care Units
Role: lead
Severe Hypoxemia : Prevalence, Treatment and Outcome
Role: lead
Study of a Strategy to Prevent Oversedation in Intensive Care Patients Under Mechanical Ventilation
Role: lead
Benefits of the Involvement of Nurses in Meetings Between Physicians and the Families of Patients in the ICU.
Role: collaborator
Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment
Role: collaborator
All 18 trials loaded